ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,932.47
1.53%
Dow Jones
43,136.63
1.45%
US Dollar vs MXN
20.5124
-0.02%
Brent Oil
80.77
1.34%
Bitcoin
99,219.72
2.81%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Pharvaris NV (PHVS) Cotización

Pharvaris NV

Pharvaris NV (PHVS)

NASDAQ
16.00
0.00
( 0.00% )
Actualizado: 10:09:42
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
16.00
Postura de Compra
15.78
Postura de Venta
16.26
Volume Operado de la Acción
7,524
15.79 Rango del Día 16.69
15.37 Rango de 52 semanas 33.00
Capitalización de Mercado [m]
836.643M
Precio Anterior
16.00
Precio de Apertura
16.56
Hora
36
@
15.79
Última hora de negociación
10:01:28
Volumen financiero
US$ 122,712
Precio Promedio Ponderado
16.3094
Volumen promedio (3 m)
75,794
Acciones en circulación
52,290,212
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-8.43
Beneficio por acción (BPA)
-1.93
turnover
-
Beneficio neto
-100.88M

Acerca de Pharvaris NV

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.pharvaris.com
Sede
Leiden, South Holland, Nld
Fundado
-
Pharvaris NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker PHVS. The last closing price for Pharvaris NV was US$16. Over the last year, Pharvaris NV shares have traded in a share price range of US$ 15.37 to US$ 33.00.

Pharvaris NV currently has 52,290,212 shares in issue. The market capitalisation of Pharvaris NV is US$836.64 million. Pharvaris NV has a price to earnings ratio (PE ratio) of -8.43.

PHVS Últimas noticias

Más noticias

Pharvaris Outlines 2025 Strategic Priorities

Initiated CHAPTER-3, the pivotal Phase 3 study of deucrictibant for prophylaxis against hereditary angioedema (HAE) attacks in 2024; topline data anticipated in 2H2026Enrollment in RAPIDe-3, the...

13 Enero 2025
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

02 Diciembre 2024
Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

13 Noviembre 2024
Edgar (US Regulatory)

Pharvaris Reports Third Quarter 2024 Financial Results and Highlights Recent Business Updates

Positive long-term extension data highlighting the differentiated profile of deucrictibant for the prevention and treatment of HAE attacks presented at recent medical congressesIntend to engage in...

13 Noviembre 2024
GlobeNewswire Inc.

Pharvaris to Participate in the Guggenheim Healthcare Innovation Conference

ZUG, Switzerland, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and...

12 Noviembre 2024
GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities

31 Octubre 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

24 Octubre 2024
Edgar (US Regulatory)

Pharvaris Presents Clinical and Non-Clinical Data Supporting HAE Development Program at the 2024 ACAAI Annual Scientific Meeting

ZUG, Switzerland, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and...

24 Octubre 2024
GlobeNewswire Inc.

Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at Upcoming Scientific Meetings

ZUG, Switzerland, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and...

16 Octubre 2024
GlobeNewswire Inc.

Pharvaris to Host Virtual Investor Event on October 23, 2024

ZUG, Switzerland, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and...

15 Octubre 2024
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-3.21-16.710046850619.2119.5915.455794216.99489269CS
4-2.71-14.484233030518.7120.4815.455003918.42336354CS
12-6.19-27.895448400222.1925.498515.457579420.92269917CS
26-2.47-13.373037357918.4725.498515.458590819.89299484CS
52-12.3-43.462897526528.33315.378842922.08905324CS
156-2.9-15.343915343918.9331.7720624813.16112967CS
260-9-362542.861.7716746414.01106554CS

PHVS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Pharvaris NV?
El precio actual de las acciones de Pharvaris NV es US$ 16.00
¿Cuántas acciones de Pharvaris NV están en circulación?
Pharvaris NV tiene 52,290,212 acciones en circulación
¿Cuál es la capitalización de mercado de Pharvaris NV?
La capitalización de mercado de Pharvaris NV es USD 836.64M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Pharvaris NV?
Pharvaris NV ha negociado en un rango de US$ 15.37 a US$ 33.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Pharvaris NV?
El ratio precio/beneficio de Pharvaris NV es -8.43
¿Cuál es la moneda de reporte de Pharvaris NV?
Pharvaris NV presenta sus resultados financieros en EUR
¿Cuál es el último beneficio anual de Pharvaris NV?
El último beneficio anual de Pharvaris NV es EUR -100.88M
¿Cuál es la dirección registrada de Pharvaris NV?
La dirección registrada de Pharvaris NV es EMMY NOETHERWEG 2, LEIDEN, SOUTH HOLLAND, 2333 BK
¿Cuál es la dirección del sitio web de Pharvaris NV?
La dirección del sitio web de Pharvaris NV es www.pharvaris.com
¿En qué sector industrial opera Pharvaris NV?
Pharvaris NV opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BKYIBIO key International Inc
US$ 3.1196
(127.71%)
135.68M
SGBXSafe and Green Holdings Corporation
US$ 1.0694
(98.04%)
164.94M
QMCOQuantum Corporation
US$ 32.64
(45.65%)
3.57M
MASS908 Devices Inc
US$ 2.81
(41.92%)
2.73M
QUBTQuantum Computing Inc
US$ 10.385
(39.77%)
60.9M
WNWMeiwu Technology Company Ltd
US$ 0.406
(-57.26%)
21.31M
ACONAclarion Inc
US$ 0.0422
(-55.95%)
84.52M
SVMHSRIVARU Holding Ltd
US$ 0.909999
(-39.33%)
2.12M
GIFTGiftify Inc
US$ 0.96
(-33.79%)
399.09k
GCTKGlucoTrack Inc
US$ 0.0835
(-31.56%)
74.07M
RGTIRigetti Computing Inc
US$ 10.4801
(17.10%)
228.4M
SGBXSafe and Green Holdings Corporation
US$ 1.0694
(98.04%)
164.94M
BKYIBIO key International Inc
US$ 3.1196
(127.71%)
135.68M
ACONAclarion Inc
US$ 0.0422
(-55.95%)
84.52M
GCTKGlucoTrack Inc
US$ 0.0835
(-31.56%)
74.07M

PHVS Discussion

Ver más
Monksdream Monksdream 4 meses hace
PHVS trying to break out of the recent channel
👍️0
Monksdream Monksdream 12 meses hace
PHVS new 52 week low
👍️0
europtiger europtiger 1 año hace
Haven’t been here in a while… but this one is just a sweet long position. Soon to be 20+ imho
👍️0
subslover subslover 2 años hace
Excellent call on the $12,00's. I just confirmed today's 12,24 is the 52-week high! :)
👍️0
europtiger europtiger 2 años hace
Yeah looking great… my average now ist even 8,30 as I bought 2 more k when she was in the 7,s so I got lucky. Let’s see, hoping for 12 break soon here

Good luck to you
👍️0
subslover subslover 2 años hace
Your doing great closed $11.20 :)
👍️0
europtiger europtiger 2 años hace
So I got now average 8,80$

Let’s see I guess
👍️0
Pt3 Pt3 2 años hace
What going on back to 7
👍️0
winna winna 2 años hace
???
👍️0
MT101 MT101 2 años hace
Ez hold. Down 12% and you think it’s bearish after a 400% run hahahahah loaded more today too.
👍️0
winna winna 2 años hace
You were saying?
👍️0
Invest-in-America Invest-in-America 2 años hace
PHVS: "RED prices at morning, sailors take warning!!" (Well, something like that.)



👍️0
Invest-in-America Invest-in-America 2 años hace
PHVS:: Were you referring to YOURSELF, Sir, with that post????? (See today's PHVS chart, below.)

👍️0
Invest-in-America Invest-in-America 2 años hace
PHVS: Where have all the smart-ass, know-it-all's gone??????? (Can't even discern conspicuous FLUFF PR's when ya see 'em!!!)

👍️0
Invest-in-America Invest-in-America 2 años hace
PHVS: The RED PRICE will edify you today --- so, ignore me if you like. Bottom line, Sir, you need a REMEDIAL course in how IGNORANT this primitive Planet is in the area of Human THERAPEUTIC Medical (so-called) "SCIENCE".
👍️0
MT101 MT101 2 años hace
I actually just loaded every more in PM. This is going to explode at open most likely another 300-400% day. Your screwed dude you should have covered yesterday!
👍️0
Invest-in-America Invest-in-America 2 años hace
It is going NOWHERE, Dude. It had its run; it's DONE Hope you didn't hold any overnight.
👍️0
MT101 MT101 2 años hace
Everything your saying is false. I sure hope your joking about being a short, your going to get toasted to a crisp today if you are.. this things about to go parabolic. Monday will probably blow up too. Easily $40+ here
👍️0
MT101 MT101 2 años hace
Shorts are trapped this is HKD 2.0
👍️0
Invest-in-America Invest-in-America 2 años hace
PHVS: It was a monster runner, that's for sure. GOOD LUCK today, however. (Pure FLUFF news, if there ever was any anywhere.)
👍️0
Invest-in-America Invest-in-America 2 años hace
PHVS: I do NOT own any of this. And, if I ran Wall Street, SHORTING any stock would be prohibited by LAW. WHY?? Because such practice is betting on a Company to LOSE value. Bottom line, SHORTING stocks is yet another example of the CORRUPT nature of American Commerce, Industry, & Government at its CORE. Similar to how in America, just ONE GUY/GAL can win a ONE-BILLION-DOLLAR lottery all for their SELFISH SELVES!!!
👍️0
MT101 MT101 2 años hace
Lol your going to lose your entire portfolio trying to short this one. Please be my guest! Love seeing shorts get their asses burned!
👍️0
MT101 MT101 2 años hace
They will try but the buying pressure is way to aggressive right now and short shares are hard to find, I checked multiple platforms. Shorts that are holding there position overnight are going to get wrecked af tomorrow
👍️0
doebop doebop 2 años hace
Agree best to wait for pop tomorrow then short if you can borrow
👍️0
Laster Laster 2 años hace
Actually Hereditary Angioedema is very hard to treat. Different than ACE induced angioedema. News looks promising but it is phase 2 data. The bigger concern is that the FDA halted their US trials on August for some reason. Therefore, the company is only doing trials outside the US.

Stock dropped $2 after hours. Let’s see how it trades Premarket.

I almost got into this at $4.70 just around noon but the stock immediately exploded to $5.80. Never seen anything like that. I saw that it was a market buy order of about 150,000 shares. Wow.
👍️0
Pt3 Pt3 2 años hace
Short can't short cuz this going to 20-30
👍️0
winna winna 2 años hace
They will short this down tomorrow
👍️0
MT101 MT101 2 años hace
Dude your so screwed if you don’t cover before tomorrow open. It’s going to $20-40
👍️0
Invest-in-America Invest-in-America 2 años hace
Watch out for RED INK tomorrow, behind this FLUFF-NEWS crap!!!
👍️0
Invest-in-America Invest-in-America 2 años hace
PHVS: My post is the TRUTH, Dude; if you can't recognize pure FLUFF Medical "NEWS" --- & about an extremely RARE disease, to boot --- well then, nobody can help you, Sir. (GOOD LUCK!!!)
👍️0
MT101 MT101 2 años hace
False. I recommend you cover your short or get burned out. This is going to $20-40 tomorrow. Tik Tok Tik Tok your running out of time.
👍️0
Invest-in-America Invest-in-America 2 años hace
PHVS: Price SOARED today, & all behind the most FLUFF news of this calendar year so far!! (Maybe of this ENTIRE year, moving forward; a firm that is LOSING money every year, & barely past the "Proof Of Concept" stage for yet ANOTHER purported treatment for whatever.)
👍️0
MT101 MT101 2 años hace
That’s good. I loaded 3k shares here around $10 range. I think this is going to $20-40 possibly. Massive news
👍️0
europtiger europtiger 2 años hace
Got me 2,5 k shares just now below 10$

Could see a nice buy out offer at some stage
👍️0
MT101 MT101 2 años hace
Going to $20-30 range
👍️0
subslover subslover 2 años hace
This stock has sure gone crazy! LMAO all the way to Wells Fargo!
👍️0
Invest-in-America Invest-in-America 2 años hace
PHVS: Indeed!!! NOT even that, per se --- really just "Proof of Concept"!! What a JOKE!! Hey, Dude, Wall Street is a GAMBLING CASINO. ANY stupid stock can SOAR; if some TRENDING/INFLUENTIAL folks or entities are pumping it, that is.

This little PUMPED PUPPY might just Close today at circa 900% UP!!!
👍️0
subslover subslover 2 años hace
HALTED for the 3rd time at 1;30 PM @ $11.93
👍️0
subslover subslover 2 años hace
$10.00 just breached.
👍️0
winna winna 2 años hace
They will short this big time
👍️0
Cosa Cosa 2 años hace
This big move is from phase 2 results?
👍️0
subslover subslover 2 años hace
Trading resumed at 12:30 pm @ $7.50. What a wild ride this turned out to be!
👍️0
davidsson10 davidsson10 2 años hace
Yes, that'll work.....
👍️0
subslover subslover 2 años hace
HALTED again 12;28pm @ $8.18
👍️0
subslover subslover 2 años hace
Trading resumed at 12:17pm @ $7.00
👍️0
subslover subslover 2 años hace
HALTED at noon @ $5.78
👍️0
subslover subslover 2 años hace
Pharvaris Reports Third Quarter 2022 Financial Results and Provides Business Update


https://www.otcmarkets.com/stock/PHVS/news/story?e&id=2400295
👍️0
subslover subslover 2 años hace
Pharvaris Announces Positive Top-line Phase 2 Data from RAPIDe-1 Study of PHVS416 for the On-Demand Treatment of HAE Attacks
https://www.otcmarkets.com/stock/PHVS/news/story?e&id=2400291
👍️0

Su Consulta Reciente

NASDAQ
PHVS
Pharvaris NV
BIT
F36428
Vontobel Financial Produ...
BIT
F37435
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados